PALVELLA THERAPEUTICS INC (PVLA) Fundamental Analysis & Valuation

NASDAQ:PVLA • US6979471090

Current stock price

127.12 USD
-3.08 (-2.37%)
At close:
127.12 USD
0 (0%)
After Hours:

This PVLA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. PVLA Profitability Analysis

1.1 Basic Checks

  • In the past year PVLA has reported negative net income.
  • PVLA had a negative operating cash flow in the past year.
  • In the past 5 years PVLA always reported negative net income.
  • In the past 5 years PVLA always reported negative operating cash flow.
PVLA Yearly Net Income VS EBIT VS OCF VS FCFPVLA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M -60M

1.2 Ratios

  • The Return On Assets of PVLA (-70.04%) is worse than 64.80% of its industry peers.
  • PVLA has a Return On Equity of -149.07%. This is in the lower half of the industry: PVLA underperforms 63.06% of its industry peers.
Industry RankSector Rank
ROA -70.04%
ROE -149.07%
ROIC N/A
ROA(3y)-39.19%
ROA(5y)-36.56%
ROE(3y)-79.34%
ROE(5y)-89.63%
ROIC(3y)N/A
ROIC(5y)N/A
PVLA Yearly ROA, ROE, ROICPVLA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for PVLA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PVLA Yearly Profit, Operating, Gross MarginsPVLA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. PVLA Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, PVLA has more shares outstanding
  • The number of shares outstanding for PVLA has been increased compared to 5 years ago.
  • PVLA has a worse debt/assets ratio than last year.
PVLA Yearly Shares OutstandingPVLA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
PVLA Yearly Total Debt VS Total AssetsPVLA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 30.20 indicates that PVLA is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of PVLA (30.20) is better than 93.04% of its industry peers.
  • PVLA has a Debt/Equity ratio of 0.63. This is a neutral value indicating PVLA is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.63, PVLA is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF N/A
Altman-Z 30.2
ROIC/WACCN/A
WACCN/A
PVLA Yearly LT Debt VS Equity VS FCFPVLA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

  • PVLA has a Current Ratio of 5.20. This indicates that PVLA is financially healthy and has no problem in meeting its short term obligations.
  • PVLA's Current ratio of 5.20 is in line compared to the rest of the industry. PVLA outperforms 56.29% of its industry peers.
  • A Quick Ratio of 5.20 indicates that PVLA has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 5.20, PVLA is in line with its industry, outperforming 57.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.2
Quick Ratio 5.2
PVLA Yearly Current Assets VS Current LiabilitesPVLA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. PVLA Growth Analysis

3.1 Past

  • PVLA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 68.81%, which is quite impressive.
  • Looking at the last year, PVLA shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
EPS 1Y (TTM)68.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.63%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 54.59% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-38%
EPS Next 2Y-32.27%
EPS Next 3Y6.87%
EPS Next 5Y54.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PVLA Yearly Revenue VS EstimatesPVLA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
PVLA Yearly EPS VS EstimatesPVLA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 20 -20 40 -40 -60

More info and screens

Find the best growth stocksShow best growing peers

0

4. PVLA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PVLA. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PVLA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PVLA Price Earnings VS Forward Price EarningsPVLA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PVLA Per share dataPVLA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-32.27%
EPS Next 3Y6.87%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PVLA Dividend Analysis

5.1 Amount

  • PVLA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PVLA Fundamentals: All Metrics, Ratios and Statistics

PALVELLA THERAPEUTICS INC

NASDAQ:PVLA (4/10/2026, 8:00:01 PM)

After market: 127.12 0 (0%)

127.12

-3.08 (-2.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-31
Earnings (Next)05-13
Inst Owners65.05%
Inst Owner Change0%
Ins Owners13.8%
Ins Owner Change1.59%
Market Cap1.82B
Revenue(TTM)N/A
Net Income(TTM)-41.72M
Analysts84.55
Price Target234.03 (84.1%)
Short Float %21.04%
Short Ratio5.82
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-17.83%
Min EPS beat(2)-20.45%
Max EPS beat(2)-15.2%
EPS beat(4)1
Avg EPS beat(4)-2.34%
Min EPS beat(4)-20.45%
Max EPS beat(4)40.1%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)20.44%
PT rev (3m)31.11%
EPS NQ rev (1m)-5.25%
EPS NQ rev (3m)-2.09%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.48%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 65.01
P/tB 65.01
EV/EBITDA N/A
EPS(TTM)-3.7
EYN/A
EPS(NY)-5.11
Fwd EYN/A
FCF(TTM)-0.76
FCFYN/A
OCF(TTM)-0.76
OCFYN/A
SpS0
BVpS1.96
TBVpS1.96
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -70.04%
ROE -149.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-39.19%
ROA(5y)-36.56%
ROE(3y)-79.34%
ROE(5y)-89.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.2
Quick Ratio 5.2
Altman-Z 30.2
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.63%
EPS Next Y-38%
EPS Next 2Y-32.27%
EPS Next 3Y6.87%
EPS Next 5Y54.59%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-140.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-131.82%
EBIT Next 3Y-52.24%
EBIT Next 5Y76.5%
FCF growth 1Y79.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y79.86%
OCF growth 3YN/A
OCF growth 5YN/A

PALVELLA THERAPEUTICS INC / PVLA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of PALVELLA THERAPEUTICS INC (PVLA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to PVLA.


Can you provide the valuation status for PALVELLA THERAPEUTICS INC?

ChartMill assigns a valuation rating of 0 / 10 to PALVELLA THERAPEUTICS INC (PVLA). This can be considered as Overvalued.


Can you provide the profitability details for PALVELLA THERAPEUTICS INC?

PALVELLA THERAPEUTICS INC (PVLA) has a profitability rating of 0 / 10.


How financially healthy is PALVELLA THERAPEUTICS INC?

The financial health rating of PALVELLA THERAPEUTICS INC (PVLA) is 4 / 10.